l 767679 has been researched along with l 734217 in 4 studies
Studies (l 767679) | Trials (l 767679) | Recent Studies (post-2010) (l 767679) | Studies (l 734217) | Trials (l 734217) | Recent Studies (post-2010) (l 734217) |
---|---|---|---|---|---|
7 | 0 | 0 | 8 | 0 | 0 |
Protein | Taxonomy | l 767679 (IC50) | l 734217 (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.0275 | |
Integrin alpha-IIb | Homo sapiens (human) | 0.0275 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brashear, KM; Breslin, MJ; Cook, JJ; Glass, JD; Gould, RJ; Halczenko, W; Hartman, GD; Holahan, MA; Hutchinson, JH; Lynch, RJ; Sitko, GR; Stranieri, MT | 1 |
Askew, BC; Bednar, B; Bednar, RA; Brashear, K; Breslin, MJ; Duggan, ME; Egbertson, MS; Fisher, TE; Gould, RJ; Halczenko, W; Hartman, GD; Hutchinson, JH; Ihle, N; Prugh, JD; Wai, JS | 1 |
Gretler, DD; Scarborough, RM | 1 |
Bednar, B; Bednar, RA; Cook, JJ; Cunningham, ME; Gould, RJ; Hartman, GD; Holahan, MA; Jumes, PA | 1 |
1 review(s) available for l 767679 and l 734217
Article | Year |
---|---|
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Design; Fibrinolytic Agents; Humans; Injections; Integrins; Molecular Mimicry; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Snake Venoms | 2000 |
3 other study(ies) available for l 767679 and l 734217
Article | Year |
---|---|
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugs.
Topics: Animals; Dogs; Drug Design; Evaluation Studies as Topic; Female; Humans; Isoquinolines; Macaca mulatta; Magnetic Resonance Spectroscopy; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship | 1996 |
Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors.
Topics: Amides; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship | 2000 |
Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azepines; beta-Alanine; Blood Platelets; Disease Susceptibility; Dogs; Epitopes; Female; Fibrinolytic Agents; Humans; Immunoglobulin G; Macaca mulatta; Macromolecular Substances; Male; Molecular Structure; Oligopeptides; Pan troglodytes; Piperazines; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Primates; Protein Binding; Sulfonamides; Thrombocytopenia | 1999 |